Chemesis International Inc. Provides Update on Year-end Audited Financials
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. Provides Update on Year-end Audited Financials
November 4, 2019
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), announces that it has experienced delays in completing its year -end audit. The delays are
attributable, among other things, to the Company’s significant growth and volume of activities undertaken
over the course of the preceding financial year. Due to such growth and activity-level, there is a need for
additional management resources and support and the Company is taking the necessary steps to identify
and address these.
The Company expects that the audit will be completed imminently.
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi -State operator with International
operations in Puerto Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it
enters new markets and is committed to differentiate itself by deploying resources in markets with major
opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis
consumers, with focus on quality and consistency.
Chemesis has facilities in both Puerto Rico and California. The Company is positioned to win additional
licenses in highly competitive merit-based US states and will expand its footprint to ensure it maintains a
first mover advantage.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
GreenSpiritRX
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Forward-Looking Information: This news release contains "forward-looking information" within the meaning of
applicable securities laws relating to statements regarding the Company's business, products and future of the
Company’s business, its product offerings and plans for sales and marketing, including with respect to the
completion of its year-end audit, its plans to continue to develop dispensaries in Puerto Rico, and its ability to
obtain licenses in additional jurisdictions. Although the Company believes that the expectations reflected in the
forward-looking information are reasonable, there can be no assurance that such expectations will prove to be
correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking
statements are subject to risks and uncertainties that may cause actual results, performance and developments to
differ materially from those contemplated by these statements depending on, among other things, the risks that
the audit may not be completed promptly, that the Company's products and plan will vary from those stated in this
news release and the Company may not be able to carry out its business plans as expected, including, but not
limited to, in relation to developing dispensaries in Puerto Rico, and its ability to obtain licenses in additional
jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend to
update any forward-looking statements or forward-looking information in this news release. Although the
Company believes that the expectations reflected in the forward-looking information are reasonable, there can be
no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales
reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release